Lipid nanoparticles as delivery vehicles for the Parietaria judaica major allergen Par j 2

References

• HolgateSTBroideDNew targets for allergic rhinitis – a disease of civilizationNat Rev Drug Discov200321190291414668811
   PubMed Web of Science ®Google Scholar
• DevereuxGThe increase in the prevalence of asthma and allergy: food for thoughtNat Rev Immunol200661186987417063187
   PubMed Web of Science ®Google Scholar
• ColomboPBonuraACostaMThe allergens of ParietariaInt Arch Allergy Immunol2003130317317912660421
   PubMed Web of Science ®Google Scholar
• AyusoRCarreiraJPoloFQuantitation of the major allergen of several Parietaria pollens by an anti-Par 1 monoclonal antibody-based ELISA. Analysis of cross-reactivity among purified Par j 1, Par o 1 and Par m 1 allergensClin Exp Allergy199525109939998556571
   PubMed Web of Science ®Google Scholar
• ScalaEAlessandriCBernardiMLCross-sectional survey on immunoglobulin E reactivity in 23,077 subjects using an allergenic molecule-based microarray detection systemClin Exp Allergy201040691192120214663
   PubMed Web of Science ®Google Scholar
• StumvollSWestritschnigKLidholmJIdentification of crossreactive and genuine Parietaria judaica pollen allergensJ Allergy Clin Immunol2003111597497912743560
   PubMed Web of Science ®Google Scholar
• BousquetJLockeyRMallingHJAllergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paperJ Allergy Clin Immunol19981024 Pt 15585629802362
   PubMed Web of Science ®Google Scholar
• ValentaRFerreiraFFocke-TejklMFrom allergen genes to allergy vaccinesAnnu Rev Immunol20102821124120192803
   PubMed Web of Science ®Google Scholar
• CompalatiERogkakouAVillaEPassalacquaGCanonicaGWEmerging sublingual immunotherapy drugsExpert Opin Pharmacother201011182963297220958111
   PubMed Web of Science ®Google Scholar
• EylesJECarpenterZCAlparHOWilliamsonEDImmunological aspects of polymer microsphere vaccine delivery systemsJ Drug Target2003118–1050951415203919
   PubMed Web of Science ®Google Scholar
• AlmeidaAJSoutoEBSolid lipid nanoparticles as a drug delivery system for peptides and proteinsAdv Drug Deliv Rev200759647849017543416
   PubMed Web of Science ®Google Scholar
• SarafSMishraDAsthanaAJainRSinghSJainNKLipid microparticles for mucosal immunization against hepatitis BVaccine2006241455616122855
   PubMed Web of Science ®Google Scholar
• PichayakornWKusonwiriyawongCLakornrachTThirapakpoomanuntSLipipunVRitthidejGCSolid lipid microparticles for oral Japanese encephalitis vaccine delivery: in vitro study in Caco-2 cells and human intestinal M-cells models and in vivo immunization in micePaper presented at: 33rd International Symposium on Controlled Release of Bioactive MaterialsJuly 22–26. 2006Vienna, Austria
   Google Scholar
• SoutoEBMüllerRHDombATobataYKumarRFarberSLipid nanoparticles (SLN and NLC) for drug deliveryNanoparticles for Pharmaceutical ApplicationsValencia, CAAmerican Scientific Publishers2007103122
   Google Scholar
• MüllerRHRadtkeMWissingSANalwaHSSolid lipid nanoparticles and nanostructured lipid carriersEncyclopedia of Nanoscience and NanotechnologyValencia, CAAmerican Scientific Publishers20044356
   Google Scholar
• DoktorovovaSGokceEOzyaziciMSoutoEBLipid matrix nanoparticles: pharmacokinetics and biopharmaceuticsCurr Nanosci200953358371
   Web of Science ®Google Scholar
• BonuraAAmorosoSLocorotondoGHypoallergenic variants of the Parietaria judaica major allergen Par j 1: a member of the nonspecific lipid transfer protein plant familyInt Arch Allergy Immunol20011261324011641604
   PubMed Web of Science ®Google Scholar
• Garcia-FuentesMTorresDAlonsoMJNew surface-modified lipid nanoparticles as delivery vehicles for salmon calcitoninInt J Pharm20052961–212213215885464
   PubMed Web of Science ®Google Scholar
• Garcia-FuentesMTorresDAlonsoMJDesign of lipid nanoparticles for the oral delivery of hydrophilic macromoleculesColloids Surf B Biointerfaces2003272–3159168
   Web of Science ®Google Scholar
• LarcheMAkdisCAValentaRImmunological mechanisms of allergen-specific immunotherapyNat Rev Immunol200661076177116998509
   PubMed Web of Science ®Google Scholar
• BrunettoBTinghinoRBraschiMCAntonicelliLPiniCIacovacciPCharacterization and comparison of commercially available mite extracts for in vivo diagnosisAllergy201065218419019796217
   PubMed Web of Science ®Google Scholar
• FockeMMarthKFlickerSValentaRHeterogeneity of commercial timothy grass pollen extractsClin Exp Allergy20083881400140818564332
   PubMed Web of Science ®Google Scholar
• FockeMMarthKValentaRMolecular composition and biological activity of commercial birch pollen allergen extractsEur J Clin Invest200939542943619302561
   PubMed Web of Science ®Google Scholar
• Traidl-HoffmannCMarianiVHochreinHPollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarizationJ Exp Med2005201462763615728240
   PubMed Web of Science ®Google Scholar
• MarianiVGillesSJakobTImmunomodulatory mediators from pollen enhance the migratory capacity of dendritic cells and license them for Th2 attractionJ Immunol2007178127623763117548598
   PubMed Web of Science ®Google Scholar
• GomezSGamazoCSan RomanBA novel nanoparticulate adjuvant for immunotherapy with Lolium perenneJ Immunol Methods20093481–21819545572
   PubMed Web of Science ®Google Scholar
• BroosSLundbergKAkagiTImmunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: implications for specific immunotherapyVaccine201028315075508520478343
   PubMed Web of Science ®Google Scholar
• PandeyRSSahuSSudheeshMSMadanJKumarMDixitVKCarbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapyInt Immunopharmacol201111892593121333772
   PubMed Web of Science ®Google Scholar
• GómezSGamazoCSan RomanBNanoparticles as an adjuvant for oral immunotherapy with allergensVaccine200725295263527117576025
   PubMed Web of Science ®Google Scholar